Viewing Study NCT00410566


Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2025-12-25 @ 7:29 PM
Study NCT ID: NCT00410566
Status: TERMINATED
Last Update Posted: 2015-03-19
First Post: 2006-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
Sponsor: Genzyme, a Sanofi Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-12
Start Date Type: None
Primary Completion Date: 2009-03
Primary Completion Date Type: ACTUAL
Completion Date: 2009-04
Completion Date Type: ACTUAL
First Submit Date: 2006-12-11
First Submit QC Date: None
Study First Post Date: 2006-12-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-03-17
Last Update Post Date: 2015-03-19
Last Update Post Date Type: ESTIMATED